Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
Reversed phase NEGATIVE ION MODEXANTHINE (M-H)-57573Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHINE (M-H)-60186Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEXANTHINE (M-H)-95270Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEXANTHINE (M-H)-106959Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHINE (M-H)-118545Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEXANTHINE (M-H)-121436Peak area normalizedfemale normoglycemic no neuropathy
Reversed phase NEGATIVE ION MODEXANTHINE (M-H)-124089Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHINE (M-H)-134385Peak area normalizedfemale normoglycemic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHINE (M-H)-140166Peak area normalizedmale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHINE (M-H)-142883Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHINE (M-H)-183399Peak area normalizedmale pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEXANTHINE (M-H)-225985Peak area normalizedmale pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEXANTHINE (M-H)-276657Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEXANTHINE (M-H)-Peak area normalizedmale diabetic no neuropathy

Return to search page
  logo